US Edition
News about GLP-1
Stay current with all the latest and breaking news about GLP-1, compare headlines and perspectives between news sources on stories happening today. In total, 919 stories have been published about GLP-1 which Ground News has aggregated in the past 3 months.
Local News Publishers
Suggest a source
Looking for a source we don't already have? Suggest one here.Top GLP-1 News
Medicare · United StatesDrugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers, the Trump administration said Tuesday.See the Story
Trump administration announces 15 new drugs for Medicare price negotiation program
71% Center coverage: 48 sources
GLP-1 · United StatesAscletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule GLP-1 receptor agonist, intended for treating type 2 diabetes mellitus.The post Ascletis initiates participant dosing in Phase II trial of ASC30 for diabetes appeared first on Clinical Trials Arena.See the Story
Ascletis Initiates Participant Dosing in Phase II Trial of ASC30 for Diabetes
68% Center coverage: 22 sources
ObesityRoche Holdings AG (OTC:RHHBY) on Tuesday released topline results from the CT388-103 Phase 2 trial of CT-388 for obesity. CT-388 is an investigational once-weekly subcutaneous injectable, dual GLP-1/GIP receptor agonist being developed for the treatment of obesity, type 2 diabetes, and other obesity-related comorbidities. Trial Data The 469-patient trial was designed to evaluate the efficacy and safety of CT-388 at low, middle, and high doses. I…See the Story
Roche's Obesity Drug Helps Almost 87% People Lose At Least 10% Weight - Roche Holding (OTC:RHHBY)
60% Center coverage: 5 sources
